0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

COMA FOLLOWING MEDICATION WITH TETRACHLORETHYLENE

J. H. Sandground, D.Sc.
JAMA. 1941;117(6):440-441. doi:10.1001/jama.1941.72820320005007c.
Text Size: A A A
Published online

On the score of safety and high efficacy especially against hookworms, tetrachlorethylene (C2Cl4), first introduced into human medicine via the veterinary field by Hall and Shillinger1 in 1925, enjoys great repute as approaching the ideal in anthelmintics. Its sponsors expressed the opinion that tetrachlorethylene would be found to be safer than carbon tetrachloride, a view which has been amply substantiated by later clinical experience. This is also borne out by the pharmacologic studies of Lamson, Robbins and Ward,2 who wrote as follows: "Tetrachlorethylene differs from carbon tetrachloride in being absorbed little, if at all, in the intestinal tract of dogs in the absence of fat. If fat is present, or if enormous doses are given to animals of different species, absorption may take place with symptoms or even death, but these symptoms are those of an overdose of hypnotics, not those of chemical change secondary

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();